[1]
“Usefulness of the measurement of ADAMS13 activity regarding a case of thrombotic thrombocytopenic purpura in a pediatric patient”, ByPC, vol. 87, no. 3, pp. 45–51, Aug. 2023, doi: 10.62073/bypc.v87i3.245.